FDA Confirmation Process Hits A Roadblock: Time For Plan B?
This article was originally published in The Tan Sheet
Executive Summary
Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation appear to be in jeopardy after the Health Committee disclosed concerns about a conduct allegation lodged against the nominee
You may also be interested in...
Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground
Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground
Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground